Friday, Dec 06, 2019 | Last Update : 06:32 AM IST

Ayurveda gets a leg-up, now part of disease management

THE ASIAN AGE. | SANGEETHA G
Published : Nov 20, 2019, 3:44 am IST
Updated : Nov 20, 2019, 3:44 am IST

The government has initiated a programme for long-term management of non-communicable diseases using Ayurveda.

Under the programme, so far 9,87,446 patients have been screened and 93,117 patients have been enrolled for long-term management through Ayurveda interventions, lifestyle modifications and yoga, the ministry said in a release.
 Under the programme, so far 9,87,446 patients have been screened and 93,117 patients have been enrolled for long-term management through Ayurveda interventions, lifestyle modifications and yoga, the ministry said in a release.

Chennai: The government has initiated a programme for long-term management of non-communicable diseases using Ayurveda.

Ministry of Ayush in collaboration with Ministry of Health & Family Welfare has implemented a project — Integration of Ayush (Ayurveda) with National Programme for Prevention and Control of Cancer, Diabetes, Cardio-vascular Diseases and Stroke (NPCDCS) programme — in a few identified districts.

Under the programme, so far 9,87,446 patients have been screened and 93,117 patients have been enrolled for long-term management through Ayurveda interventions, lifestyle modifications and yoga, the ministry said in a release.

The Central Council for Research in Ayurvedic Sciences (CCRAS) has also developed AYUSH-82, a formulation and has commercialised it for wider usage. It has also developed AYUSH-QOL-2C for improving quality of life of breast and cervical cancer patients in collaboration with the All-India Institute of Medical Sciences (AIIMS), Delhi and St. Jones Medical College (Bengaluru).

In addition to this, CCRAS has validated 82 classical Ayurvedic formulations and 11 new drugs on more than 32 diseases conditions, lifestyle diseases such as diabetes, bronchial asthma, hypertension, irritable bowel syndrome (IBS), iron deficiency anaemia, osteoarthritis, rheumatoid arthritis, haemorrhoids, computer vision syndrome and obesity.

The ministry said to encourage the export of Ayush products, under Central Sector Scheme for promotion of International Co-operation, incentives are provided to Ayush drug manufacturers, entrepreneurs, Ayush institutions and hospitals for registration of Ayush products with regulatory bodies of different countries.

The regulatory bodies named in the release include Food and Drug Administration (FDA) of United States/Europe, the Middle East and Africa (EMEA)/ Medicines and Healthcare products Regulatory Agency of the United Kingdom (UK-MHRA)/ and Natural and Non-prescription Health Products Directorate of Canada (NHPD).

Tags: ayurveda, ccras